company

BIO-TECH AS

1384 ASKER

Return on Equity
−38,82 %
Current Ratio
2 349
Debt-to-Equity Ratio
0,05
Key figures (NOK)2022
Revenue84 000
Net Income−3 929 000
Total Assets10 646 000
Total Equity10 120 000
Income (NOK)2022
Revenue84 000
Expenditure76 000
Operating Profit8 000
Financial Income332 000
Financial Costs4 266 000
Financial Balance−3 934 000
Earnings Before Tax−3 926 000
Tax4 000
Net Income−3 929 000
Balance (NOK)2022
Total Fixed Assets1 250 000
Total Current Assets9 396 000
Total Assets10 646 000
Total Retained Equity8 109 000
Total Equity10 120 000
Total Long-Term Debt522 000
Total Current Debt4 000
Total Equity and Debt10 646 000
Cash flow (NOK)2022
Sales Income0
Other Income84 000
Revenue84 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure76 000
Operating Profit8 000
Financial Income332 000
Financial Costs4 266 000
Financial Balance−3 934 000
Dividends0
Net Income−3 929 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate1 250 000
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets1 250 000
Total Fiancial Fixed Assets0
Total Fixed Assets1 250 000
Stock0
Total Investments9 220 000
Cash, Bank176 000
Total Current Assets9 396 000
Total Assets10 646 000
Total Equity10 120 000
Short-Term Group Debt0
Total Long-Term Debt522 000
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt4 000
Total Equity and Debt10 646 000
Financial indicators2022
Return on Equity−38,82 %
Debt-to-Equity Ratio0,05
Operating Profit Margin9,52 %
Current Ratio2 349
Quick Ratio2 349
Equity Ratio0,95
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English